Global Tenosynovial Giant Cell Tumor Treatment Market to Grow at 3.7% During 2024-2032, Impelled by Increasing Awareness About Early Diagnosis and Treatment Options

June 16, 2022 | Healthcare

According to the latest report by IMARC Group, titled “Tenosynovial Giant Cell Tumor Treatment Market Report by Disease Type (Localized Giant Cell Tumor, Diffuse Giant Cell Tumor), Treatment Type (Surgery, Radiation Therapy, Drug Therapy), End-User (Surgical Clinics, Hospitals), and Region 2024-2032," the global tenosynovial giant cell tumor treatment market is expected to grow at a CAGR of 3.7% during 2024-2032. Tenosynovial giant cell tumor (TGCT) is a rare type of tumor that affects the synovial membrane of joints, tendons, and bursae and causes them to thicken or overgrow. They are benign; however, the progressive disease that gradually worsens and can damage the bone. It includes common symptoms, such as swelling, tenderness, stiffness, pain and reduced mobility in the affected limb or joints. TGCT treatment procedures mainly involve surgery, radiation, and drug therapy, which aid in significantly improving the range of motion in the affected joint.

Global Tenosynovial Giant Cell Tumor Treatment Market Trends:

The increasing prevalence of TGCT across the globe is majorly driving the market growth. Additionally, the rising consumer awareness of its early diagnosis and treatment to control the spread of the tumor is acting as another growth-inducing factor. Apart from this, various advancements in medications and surgical procedures, such as arthroscopy and total joint replacement surgeries, are providing an impetus to the market growth. Additionally, rapid improvements in the treatment and diagnosis of tenosynovial giant cell tumors and the wide availability of advanced therapies, including radiation and pharmacotherapy, are positively impacting the market growth. Moreover, the increasing establishment of effective diagnostic and treatment facilities, especially in developing nations, and the continuous investments by pharmaceutical companies to engineer novel formulations for TGCT are creating a positive outlook for the market. Other factors, including significant growth in the healthcare industry, extensive research and development (R&D) activities, and the implementation of various government initiatives focusing on creating awareness of the early diagnosis and treatment of TGCT, are anticipated to drive the market toward growth.

Market Summary:

  • On the basis of the disease type, the market has been bifurcated into localized and diffuse giant cell tumor.
  • Based on the treatment type, the market has been divided into surgery, radiation therapy, and drug therapy.
  • On the basis of the end user, the market has been classified into surgical clinics and hospitals.
  • Based on the region, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and Others) Latin America (Brazil, Mexico and Others), Middle East and Africa(South Africa, Saudi Arabia).
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of these players include Daiichi Sankyo Company Limited, Deciphera Pharmaceuticals Inc., Five Prime Therapeutics Inc., and Novartis AG.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Hstorical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Disease Type, Treatment Type, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Netherlands, Spain, China, Japan, India, Brazil, Mexico, South Africa, Saudi Arabia
Companies Covered Daiichi Sankyo Company Limited, Deciphera Pharmaceuticals Inc., Five Prime Therapeutics Inc., and Novartis AG
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Tenosynovial Giant Cell Tumor Treatment Market to Grow at 3.7% During 2024-2032, Impelled by Increasing Awareness About Early Diagnosis and Treatment Options
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More